Changing landscape of diabetes in Asia – What are the unmet needs?

Author:

Luk Andrea OY1234ORCID

Affiliation:

1. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong China

2. Hong Kong Institute of Diabetes and Obesity The Chinese University of Hong Kong Hong Kong China

3. Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong China

4. Phase 1 Clinical Trial Centre The Chinese University of Hong Kong Hong Kong China

Abstract

ABSTRACTThe incidence rates of type 2 diabetes among adults in Asia have been stable, but the rates in youth and young adults have increased. In territory‐wide surveillance in Hong Kong, Special Administrative Region of People's Republic of China, all‐cause mortality rates among people with diabetes have exhibited a declining trend in the past 15 years, with a narrowing in the mortality gap between people with and without diabetes. At the same time, the improvement in survival resulted in a changing age structure and disease profile of people with diabetes, towards an increasing proportion of older people with long diabetes duration and multi‐morbidities. Reductions in event rates were not observed in the youngest age group who also had the least gains in risk factor control and uptake in organ protective drugs over time. A young age at diabetes diagnosis, associated with exposure to high glycemic burden from an early age, predicted higher risks of complications and premature mortality compared with later‐onset of diabetes. People presenting with type 2 diabetes below 40 years of age were 5‐fold more likely to die and their life expectancy was shortened by 8 years than age‐matched counterparts without diabetes. Analysis of population‐based data in Hong Kong Chinese identified hypertension followed by chronic kidney disease as the leading contributor to mortality in young people, indicating that efforts to optimize non‐glycemic risk factors and organ protection are as important in young individuals as it is in the older population.

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3